Opti Capital Management, LP - Q2 2023 holdings

$1.18 Billion is the total value of Opti Capital Management, LP's 49 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 81.2% .

 Value Shares↓ Weighting
BuyENVISTA HOLDINGS CORPORATIONnote 2.375% 6/0$78,199,460
+46.8%
46,600,000
+75.2%
6.61%
+53.5%
BuyWORKIVA INCnote 1.125% 8/1$72,512,232
+59.2%
51,442,000
+59.8%
6.13%
+66.5%
BuyFIVE9 INCnote 0.500% 6/0$59,113,005
+99.8%
61,090,000
+93.9%
5.00%
+108.9%
BuyALTERYX INCnote 0.500% 8/0$51,170,859
+3.0%
54,149,000
+2.2%
4.33%
+7.7%
BuyBLACKLINE INCnote 3/1$49,803,858
+79.8%
58,500,000
+80.0%
4.21%
+88.0%
NewHUBSPOT INCnote 0.375% 6/0$49,079,42225,653,000
+100.0%
4.15%
BuyALARM COM HLDGS INCnote 1/1$47,935,631
+12.5%
56,065,000
+10.9%
4.05%
+17.6%
BuyNUVASIVE INCnote 0.375% 3/1$32,216,544
+77.8%
35,330,000
+73.8%
2.72%
+85.9%
NewINSULET CORPnote 0.375% 9/0$28,254,04320,500,000
+100.0%
2.39%
New3D SYS CORP DELnote 11/1$22,845,87030,000,000
+100.0%
1.93%
BuyLYFT INCnote 1.500% 5/1$22,572,500
+307.8%
25,000,000
+300.0%
1.91%
+326.8%
BuyOPKO HEALTH INCnote 4.500% 2/1$20,563,819
+47.3%
20,235,000
+32.8%
1.74%
+54.1%
BuyENVESTNET INCnote 0.750% 8/1$20,011,840
+97.3%
21,752,000
+94.2%
1.69%
+106.3%
BuyVAREX IMAGING CORPnote 4.000% 6/0$19,254,594
+39.1%
15,050,000
+19.9%
1.63%
+45.5%
NewNOVOCURE LTDnote 11/0$15,570,00018,000,000
+100.0%
1.32%
NewPACIRA BIOSCIENCES INCnote 0.750% 8/0$14,914,37916,052,000
+100.0%
1.26%
BuySPOTIFY USA INCnote 3/1$14,909,510
+18.6%
17,500,000
+16.7%
1.26%
+24.0%
NewINTEGRA LIFESCIENCES HLDGS Cnote 0.500% 8/1$14,750,19216,114,000
+100.0%
1.25%
Buy8X8 INC NEWnote 0.500% 2/0$14,148,985
+116.8%
14,835,000
+111.6%
1.20%
+126.5%
BuyBANDWIDTH INCnote 0.250% 3/0$11,401,411
+9.9%
14,501,000
+9.2%
0.96%
+15.0%
BuyTHE REALREAL INCnote 3.000% 6/1$11,385,050
+20.0%
16,500,000
+10.0%
0.96%
+25.4%
NewMANNKIND CORPnote 2.500% 3/0$10,593,00010,000,000
+100.0%
0.90%
BuyMODEL N INCnote 2.625% 6/0$10,487,300
+45.2%
8,500,000
+41.7%
0.89%
+51.9%
NewBLOCK INCnote 5/0$8,325,00010,000,000
+100.0%
0.70%
NewCUTERA INCnote 2.250% 3/1$5,562,1576,370,000
+100.0%
0.47%
NewDOCUSIGN INCnote 1/1$4,840,0005,000,000
+100.0%
0.41%
NewCUTERA INCnote 2.250% 6/0$4,337,9546,900,000
+100.0%
0.37%
NewPTC THERAPEUTICS INCnote 1.500% 9/1$3,080,5053,000,000
+100.0%
0.26%
RPD NewRAPID7 INC$662,08414,622
+100.0%
0.06%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SUPERNUS PHARMACEUTICALS INC14Q1 20236.9%
NEW RELIC INC14Q1 20237.6%
8X8 INC NEW13Q3 20237.4%
MANDIANT INC12Q1 20229.9%
NUTANIX INC12Q4 20227.3%
OPKO HEALTH INC12Q3 20232.1%
INSIGHT ENTERPRISES INC10Q3 20235.6%
ALTERYX INC10Q3 20234.6%
IONIS PHARMACEUTICALS INC10Q1 20233.6%
MODEL N INC10Q3 20231.7%

View Opti Capital Management, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View Opti Capital Management, LP's complete filings history.

Compare quarters

Export Opti Capital Management, LP's holdings